193 related articles for article (PubMed ID: 35169873)
1. The fear of cancer recurrence and progression in patients with pancreatic cancer.
Pijnappel EN; Dijksterhuis WPM; Sprangers MAG; Augustinus S; de Vos-Geelen J; de Hingh IHJT; Molenaar IQ; Busch OR; Besselink MG; Wilmink JW; van Laarhoven HWM;
Support Care Cancer; 2022 Jun; 30(6):4879-4887. PubMed ID: 35169873
[TBL] [Abstract][Full Text] [Related]
2. Fear of progression among postoperative patients with newly diagnosed lung cancer: a cross-sectional survey in China.
Chen R; Yang H; Zhang H; Chen J; Liu S; Wei L
BMC Psychol; 2023 May; 11(1):168. PubMed ID: 37217966
[TBL] [Abstract][Full Text] [Related]
3. Trajectories of fear of progression in nasopharyngeal carcinoma patients receiving proton and heavy ion therapy.
Zheng M; Wang S; Zhu Y; Wan H
Support Care Cancer; 2023 Oct; 31(12):630. PubMed ID: 37843679
[TBL] [Abstract][Full Text] [Related]
4. Fear of progression in parents of childhood cancer survivors: A dyadic data analysis.
Peikert ML; Inhestern L; Krauth KA; Escherich G; Rutkowski S; Kandels D; Bergelt C
Psychooncology; 2020 Oct; 29(10):1678-1685. PubMed ID: 32779255
[TBL] [Abstract][Full Text] [Related]
5. Fear of cancer progression in patients with stage IA malignant melanoma.
Wagner T; Augustin M; Blome C; Forschner A; Garbe C; Gutzmer R; Hauschild A; Heinzerling L; Livingstone E; Loquai C; Schadendorf D; Terheyden P; Mueller-Brenne T; Kähler KC
Eur J Cancer Care (Engl); 2018 Sep; 27(5):e12901. PubMed ID: 30126009
[TBL] [Abstract][Full Text] [Related]
6. The effect of fear of progression on quality of life among breast cancer patients: the mediating role of social support.
Ban Y; Li M; Yu M; Wu H
Health Qual Life Outcomes; 2021 Jul; 19(1):178. PubMed ID: 34253195
[TBL] [Abstract][Full Text] [Related]
7. Fear of disease progression in adult ambulatory patients with brain cancer: prevalence and clinical correlates.
Goebel S; Mehdorn HM
Support Care Cancer; 2019 Sep; 27(9):3521-3529. PubMed ID: 30684045
[TBL] [Abstract][Full Text] [Related]
8. Increased fear of progression in cancer patients with recurrence.
Shim EJ; Shin YW; Oh DY; Hahm BJ
Gen Hosp Psychiatry; 2010; 32(2):169-75. PubMed ID: 20302991
[TBL] [Abstract][Full Text] [Related]
9. Bypass surgery versus palliative pancreaticoduodenectomy in patients with advanced ductal adenocarcinoma of the pancreatic head, with an emphasis on quality of life analyses.
Schniewind B; Bestmann B; Kurdow R; Tepel J; Henne-Bruns D; Faendrich F; Kremer B; Kuechler T
Ann Surg Oncol; 2006 Nov; 13(11):1403-11. PubMed ID: 17009141
[TBL] [Abstract][Full Text] [Related]
10. Fear of progression and its role in the relationship of cancer-related fatigue with physical functioning and global quality of life - A register-based study among hematological cancer survivors.
Esser P; Götze H; Mehnert-Theuerkauf A; Knoop H; Kuba K
J Psychosom Res; 2019 Dec; 127():109844. PubMed ID: 31707130
[TBL] [Abstract][Full Text] [Related]
11. Self-efficacy and fear of cancer progression during the year following diagnosis of breast cancer.
Melchior H; Büscher C; Thorenz A; Grochocka A; Koch U; Watzke B
Psychooncology; 2013 Jan; 22(1):39-45. PubMed ID: 21898655
[TBL] [Abstract][Full Text] [Related]
12. Is patient participation in multidisciplinary tumor conferences associated with their fear of progression?
Diekmann A; Schellenberger B; Reck S; Heuser C; Geiser F; Wirtz M; Ansmann L; Ernstmann N
Psychooncology; 2021 Sep; 30(9):1572-1581. PubMed ID: 34004041
[TBL] [Abstract][Full Text] [Related]
13. Overall survival of patients with recurrent pancreatic cancer treated with systemic therapy: a retrospective study.
Gbolahan OB; Tong Y; Sehdev A; O'Neil B; Shahda S
BMC Cancer; 2019 May; 19(1):468. PubMed ID: 31101022
[TBL] [Abstract][Full Text] [Related]
14. Are fear of cancer recurrence and fear of progression equivalent constructs?
Coutts-Bain D; Sharpe L; Pradhan P; Russell H; Heathcote LC; Costa D
Psychooncology; 2022 Aug; 31(8):1381-1389. PubMed ID: 35470502
[TBL] [Abstract][Full Text] [Related]
15. Fear of disease progression and relevant correlates in acute leukemia patients prior to allogeneic hematopoietic stem cell transplantation.
Thiele S; Goebel S; Kröger N; Pedersen A
Psychooncology; 2020 Aug; 29(8):1248-1254. PubMed ID: 32323380
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of two group therapies to reduce fear of progression in cancer patients.
Herschbach P; Book K; Dinkel A; Berg P; Waadt S; Duran G; Engst-Hastreiter U; Henrich G
Support Care Cancer; 2010 Apr; 18(4):471-9. PubMed ID: 19865833
[TBL] [Abstract][Full Text] [Related]
17. Fear of Cancer Progression: A Comparison between the Fear of Progression Questionnaire (FoP-Q-12) and the Concerns about Recurrence Questionnaire (CARQ-4).
Hinz A; Schulte T; Mehnert-Theuerkauf A; Richter D; Sender A; Brock H; Friedrich M; Briest S
Healthcare (Basel); 2024 Feb; 12(4):. PubMed ID: 38391810
[TBL] [Abstract][Full Text] [Related]
18. Palliative partial pancreaticoduodenectomy impairs quality of life compared to bypass surgery in patients with advanced adenocarcinoma of the pancreatic head.
Walter J; Nier A; Rose T; Egberts JH; Schafmayer C; Kuechler T; Broering DC; Schniewind B
Eur J Surg Oncol; 2011 Sep; 37(9):798-804. PubMed ID: 21767928
[TBL] [Abstract][Full Text] [Related]
19. Fear of progression in patients 6 months after cancer rehabilitation-a- validation study of the fear of progression questionnaire FoP-Q-12.
Hinz A; Mehnert A; Ernst J; Herschbach P; Schulte T
Support Care Cancer; 2015 Jun; 23(6):1579-87. PubMed ID: 25412727
[TBL] [Abstract][Full Text] [Related]
20. Quality of life and outcome of patients with metastatic pancreatic cancer receiving first-line chemotherapy with nab-paclitaxel and gemcitabine: Real-life results from the prospective QOLIXANE trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registry.
Al-Batran SE; Hofheinz RD; Reichart A; Pauligk C; Schönherr C; Schlag R; Siegler G; Dörfel S; Koenigsmann M; Zahn MO; Schubert J; Aldaoud A; Höffkes HG; Schulz H; Hahn L; Uhlig J; Blau W; Stauch M; Weniger J; Wolf M; Jacobasch L; Bildat S; Wehmeyer J; Homann N; Trojan J; Waidmann O; Fietz T; Feustel HP; Groschek M; Wierecky J; Waibel K; Mahlmann S; Schwindel U; Peters U; Schuch G; Pink D; Eschenburg H; Wörns MA; Harich HD; von Weikersthal LF; Däßler KU; Behringer DM; Messmann H; Kretzschmar A; Gallmeier E; Forstbauer H; Kunzmann V; Papke J; Büchner-Steudel P; Vehling-Kaiser U; Springfeld C; Vogel A; Ettrich TJ; Schaaf M; Hausen GZ; Götze TO;
Int J Cancer; 2021 Mar; 148(6):1478-1488. PubMed ID: 33038277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
